Skip to Content

Acepromazine Maleate Tablets, USP

This page contains information on Acepromazine Maleate Tablets, USP for veterinary use.
The information provided typically includes the following:
  • Acepromazine Maleate Tablets, USP Indications
  • Warnings and cautions for Acepromazine Maleate Tablets, USP
  • Direction and dosage information for Acepromazine Maleate Tablets, USP

Acepromazine Maleate Tablets, USP

This treatment applies to the following species:
Manufacturer: Clipper (Phoenix Pharm.)

10 mg or 25 mg per Tablet

NADA 117-532, Approved by FDA

For use in dogs only.

Acepromazine Maleate Tablets, USP Caution

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

EACH TABLET CONTAINS: 10 mg or 25 mg acepromazine maleate.

Description

Acepromazine maleate, a potent neuroleptic agent with a low order of toxicity, is of particular value in the tranquilization of dogs. Its rapid action and lack of hypnotic effect are added advantages.

CHEMISTRY: 2-acetyl-10-(3-dimethyl-aminopropyl) phenothiazine hydrogen maleate.

Acepromazine Maleate

MODE OF ACTION: Acepromazine maleate has a depressant effect on the central nervous system and therefore causes sedation, muscular relaxation and a reduction in spontaneous activity. It acts rapidly, exerting a prompt and pronounced calming effect. It is an effective preanesthetic agent and lowers the dosage requirement of general anesthetics.

Acepromazine Maleate Tablets, USP Indications

As an aid in tranquilization and as a preanesthetic agent in dogs.

Acepromazine Maleate Tablets can be used as an aid in controlling intractable animals during examination, treatment, grooming, x-ray and minor surgical procedures.

Dosage and Administration

Dogs: 0.25-1.0 mg/lb of body weight. Dosage may be repeated as required.

ANIMAL SAFETY: Acute and chronic toxicity studies have shown a very low order of toxicity for acepromazine maleate.

A safety study using elevated dosages of acepromazine maleate demonstrated no adverse reactions even when administered at three times the upper limit of the recommended daily dosage (3.0 mg/lb body weight). The clinical observation for this high dosage was mild depression which disappeared in most dogs 24 hours after termination of dosing.

The only occurrence of adverse reaction during numerous clinical trials was a very mild respiratory distress (reverse sneeze) which was transient in nature and had no effect on the desired action of the drug.

Contraindications

Phenothiazines may potentiate the toxicity of organophosphates. Therefore, do not use acepromazine maleate to control tremors associated with organic phosphate poisoning.

Do not use in conjunction with organophosphorus vermifuges or ectoparasiticides, including flea collars.

Do not use with procaine hydrochloride.

Warning

Do not use in animals intended for human consumption.

Precautions

Tranquilizers are potent central nervous system depressants, and they can cause marked sedation with suppression of the sympathetic nervous system. Tranquilizers can produce prolonged depression or motor restlessness when given in excessive amounts or when given to sensitive animals. Tranquilizers are additive in action to the actions of other depressants and will potentiate general anesthesia. Tranquilizers should be administered in smaller doses and with greater care during general anesthesia and also to animals exhibiting symptoms of stress, debilitation, cardiac disease, sympathetic blockade, hypovolemia or shock. Acepromazine, like other phenothiazine derivatives, is detoxified in the liver; therefore, it should be used with caution on animals with a previous history of liver dysfunction or leukopenia.

Epinephrine is contraindicated for treatment of acute hypotension produced by phenothiazine-derivative tranquilizers since further depression of blood pressure can occur.

Phenothiazines should be used with caution when followed by epidural anesthetic procedures because they may potentiate the arterial hypotensive effects of local anesthetics.

Adverse Reactions

A few rare but serious occurrences of idiosyncratic reactions to acepromazine may occur in dogs following oral or parenteral administration. These potentially serious adverse reactions include behavioral disorders in dogs such as aggression, biting/chewing, and nervousness.

To report suspected adverse reactions, to obtain a Material Safety Data Sheet or for technical assistance, call 1-866-638-2226.

Storage

Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C (between 59° and 86°F).

How Supplied

Acepromazine Maleate Tablets are available in 10 & 25 mg concentrations, and are quarter scored for convenience of administration. Both concentrations are available in bottles of 100 and 500 tablets.

NDC 57319-445-13 - 10 mg - 100 tablets

NDC 57319-445-15 - 10 mg - 500 tablets

NDC 57319-446-13 - 25 mg - 100 tablets

NDC 57319-446-15 - 25 mg - 500 tablets

Keep out of reach of children.

PHOENIX™

Manufactured for: Clipper Distributing Company, LLC, St. Joseph, MO 64507

Trademarks are property of Clipper Distributing Company, LLC.

Net Contents:

NDC

 

100 Tablets (10 mg)

57319-445-13

670119-03

80733577

80728581, R.0

Revised 04/2012

500 Tablets (10 mg)

57319-445-15

670113L-02-0203

100 Tablets (25 mg)

57319-446-13

670228-00

80733623

80728670, R.0

Revised 04/2012

500 Tablets (25 mg)

57319-446-15

670230-00

80732279

80728743, R.0

Revised 04/2012

NAC No.: 12560013

CLIPPER DISTRIBUTING CO., LLC
PHOENIX PHARMACEUTICAL INC.

1302 SOUTH 59 STREET, ST. JOSEPH, MO, 64507
Telephone:   816-364-5777
Order Desk:   800-759-3644
Fax:   816-364-4969
Website:   www.clipperdist.net
Email:   info@clipperdist.net
Every effort has been made to ensure the accuracy of the Acepromazine Maleate Tablets, USP information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-08-21

Hide